Research publications |
| Differentially expressed genes in Chronic Fatigue
Syndrome / Myalgic Encephalomyelitis (CFS/ME) patients reveal seven
subtypes
with distinct clinical phenotypes. Jonathan R Kerr, Robert Petty,
Beverley Burke, John Gough, David Fear, Lindsey I Sinclair, Derek L Mattey, Selwyn CM Richards, Jane Montgomery, Don A Baldwin, Paul Kellam, Tim J Harrison, George E Griffin, Janice Main, Derek Enlander, David J Nutt, Stephen T Holgate. Journal of Infectious Diseases 2007 (in press). |
|
| Current research priorities in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME):disease mechanisms, a diagnostic test and specific treatments. Jonathan R Kerr, Peter Christian, Andrea Hodgetts, Paul R Langford, Lakshmi D Devanur, Robert Petty, Beverley Burke, Lindsey I Sinclair, Selwyn C M Richards, Jane Montgomery, Clare McDermott, Tim J Harrison, Paul Kellam, David J Nutt and Stephen T Holgate. Journal of Clinical Pathology 2007;60(2):113-6. | |
| Chronic fatigue syndrome. Devanur LD, Kerr JR. Journal of Clinical Virology 2006;37(3):139-50. | |
| Gene expression in peripheral blood mononuclear cells (PBMC) of CFS patients. Kaushik N, Fear DJ, Richards SC, McDermott CR, Nuwaysir EF, Kellam P, Harrison TJ, Wilkinson RJ, Tyrrell DA, Holgate ST, Kerr JR. Journal of Clinical Pathology / Molecular Pathology 2005;58(8):826-32. | |
| Single nucleotide polymorphisms (SNPs) associated with symptomatic infection and differential human gene expression in normal seropositive persons each implicate the cytoskeleton, integrin signalling and oncosuppression in the pathogenesis of human parvovirus B19 infection. Kerr JR, Kaushik N, Fear DJ, Baldwin D, Nuwaysir EF, Adcock IM. Journal of Infectious Diseases 2005;192(2):276-86. | |
| Identification of novel expressed sequences, up-regulated in the leucocytes
of chronic fatigue syndrome patients. Powell R, Ren J, Lewith G, Barclay W, Holgate S, Almond J. Clin Exp Allergy. 2003 Oct;33(10):1450-6. |
|
| Enterovirus related metabolic myopathy: a postviral fatigue syndrome. Lane RJ, Soteriou BA, Zhang H, Archard LC. J Neurol Neurosurg Psychiatry. 2003 Oct;74(10):1382-6. | |
| Cytokines in parvovirus B19 infection as an
aid to understanding chronic fatigue syndrome. Kerr JR, Tyrrell DA. Curr Pain Headache Rep. 2003 Oct;7(5):333-41. Review. |
|
| Cytokine gene polymorphisms associated with
symptomatic parvovirus B19 infection. Kerr JR, McCoy M, Burke B, Mattey DL, Pravica V, Hutchinson IV. J Clin Pathol. 2003 Oct;56(10):725-7. |
|
| Successful intravenous immunoglobulin therapy
in 3 cases of parvovirus B19-associated chronic fatigue syndrome. Kerr JR, Cunniffe VS, Kelleher P, Bernstein RM, Bruce IN. Clin Infect Dis. 2003 May 1;36(9):e100-6. Epub 2003 Apr 22. |
|
| Association of symptomatic acute human parvovirus
B19 infection with human leukocyte antigen class I and II alleles. Kerr JR, Mattey DL, Thomson W, Poulton KV, Ollier WE. J Infect Dis. 2002 Aug 15;186(4):447-52. |
|
| Chronic fatigue syndrome and arthralgia following parvovirus B19 infection. Kerr JR, Bracewell J, Laing I, Mattey DL, Bernstein RM, Bruce IN, Tyrrell DA. J Rheumatol. 2002 Mar;29(3):595-602. | |
| Circulating tumour necrosis factor-alpha and
interferon-gamma are detectable during acute and convalescent parvovirus B19 infection and are associated with prolonged and chronic fatigue. Kerr JR, Barah F, Mattey DL, Laing I, Hopkins SJ, Hutchinson IV, Tyrrell DA. J Gen Virol. 2001 Dec;82(Pt 12):3011-9. |
|
| Quantitative analysis of viral RNA kinetics
in coxsackievirus B3-induced murine myocarditis: biphasic pattern of clearance following acute infection, with persistence of residual viral RNA throughout and beyond the inflammatory phase of disease. Reetoo KN, Osman SA, Illavia SJ, Cameron-Wilson CL, Banatvala JE, Muir P. J Gen Virol. 2000 Nov;81(Pt 11):2755-62. |
|
| Development and evaluation of quantitative-competitive
PCR for quantitation of coxsackievirus B3 RNA in experimentally infected murine tissues. Reetoo KN, Osman SA, Illavia SJ, Banatvala JE, Muir P. J Virol Methods. 1999 Oct;82(2):145-56. |
|
| Demonstration of delayed recovery from fatiguing
exercise in chronic fatigue syndrome. Paul L, Wood L, Behan WM, Maclaren WM. Eur J Neurol. 1999 Jan;6(1):63-9. |
|
| In vitro study of muscle aerobic metabolism in chronic fatigue syndrome. Behan WM, Holt I, Kay DH, Moonie P. Journal of Chronic Fatigue Syndrome 1999:5. | |
| Is chronic fatigue syndrome a muscle disease? Behan WM. Muscle Exercise Intolerance & Contractures, edited by G Serratrice. Pergamon Press, New York, 1999. | |
Muscle fibre characteristics and lactate responses
to exercise in chronic |
|
| Heterogeneity in chronic fatigue syndrome: evidence from magnetic resonance spectroscopy of muscle. Lane RJ, Barrett M, Taylor D, Kemp G, Lode R. Neuromuscular Disorders 1998;8:204-9. | |
In vitro studies of oxidative muscle metabolism in chronic fatigue syndrome. Behan WM, Holt I, Iay D, Moonie P. Journal of Chronic Fatigue Syndrome 1998;5:32-37. |
|
| top |